David Dwyer
Internal Medicine · Noblesville, INNPI 1487715074
Payments from drug & device makers
Across 137 payments — averaging $20.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$460
- Supernus Pharmaceuticals, Inc.$351
- Teva Pharmaceuticals USA, Inc.$254
- Arbor Pharmaceuticals, Inc.$189
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$184
- Neurocrine Biosciences, Inc.$175
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,746100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 24 | $460 |
| Supernus Pharmaceuticals, Inc. | 11 | $351 |
| Teva Pharmaceuticals USA, Inc. | 14 | $254 |
| Arbor Pharmaceuticals, Inc. | 1 | $189 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $184 |
| Neurocrine Biosciences, Inc. | 8 | $175 |
| Otsuka America Pharmaceutical, Inc. | 8 | $139 |
| Johnson & Johnson | 7 | $138 |
| Gilead | 5 | $112 |
| Lundbeck LLC | 5 | $80 |
| Sunovion Pharmaceuticals Inc. | 8 | $70 |
| Corium, LLC | 4 | $64 |
| Indivior Inc. | 4 | $62 |
| E.r. Squibb & Sons, L.L.C. | 4 | $61 |
| Pfizer | 3 | $47 |
| Novartis | 3 | $45 |
| Azurity Pharmaceuticals, Inc. | 2 | $41 |
| Alkermes, Inc. | 2 | $41 |
| Almatica Pharma LLC | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $32 |
| Adlon Therapeutics L.p. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $26 |
| Astellas Pharma US Inc | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Shire North American Group Inc | 1 | $20 |
| Exact Sciences | 1 | $16 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,746 in reported general payments places this provider in the 85th percentile of 1,747 internal medicine providers in Indiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 39 | $50,882 |
| MounjaroTirzepatide | 29 | $31,016 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $26,979 |
| EliquisApixaban | 18 | $24,122 |
| TradjentaLinagliptin | 25 | $6,561 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 28 | $3,569 |
| Humalog Kwikpen U-100Insulin Lispro | 12 | $2,015 |
| Pregabalin | 38 | $1,722 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 45 | $1,444 |
| Gabapentin | 105 | $1,370 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,173 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 18 | $1,128 |
| Levothyroxine Sodium | 108 | $1,096 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 21 | $1,070 |
| Tramadol Hcl | 86 | $1,064 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $47 | $24,12218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,747 internal medicine providers in Indiana.
Other internal medicine in Noblesville
- Robert BuynakValparaiso$24.2M
- Mohammed AllawNewburgh$3.6M
- Raj VuppalanchiIndianapolis$3.4M
- Phillip TothIndianapolis$3.2M
- George CornettFranklin$1.3M
- Ajita NarayanLafayette$951K
- Abhinav SinghGreenwood$738K
- Georgiann LinnemeierIndianapolis$692K
- Wa'el BakdashAnderson$625K
- Rita SchmidSouth Bend$599K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.